|
|
||||||||
Electronic Letters to:
|
|
Electronic letters published:
|
|
|||
|
Manfred Lammers Dade Behring Marburg GmbH, Marburg, Germany
Send letter to journal:
Manfred_Lammers{at}dadebehring.com Manfred Lammers
|
The authors present an interesting report about similar D-Dimer concentrations in citrated plasma and serum. They do not mention any correction for the dilution of the citrated plasma, which will vary between 15 % and 19 % for hematocrit values between 0.37 and 0.54. This implies that the corrected D-Dimer concentration in citrated plasma will be higher than that in serum, in contrast to previous concerns. It would be interesting to know whether this difference originates from a loss of D -Dimer during clotting or by matrix effects of citrated plasma in the assay used. |
|||
|
|
|||
|
Wolfgang Korte IKCH, kantonsspital, 9007 St. Gallen
Send letter to journal:
wolfgang.korte{at}gd-ikch.sg.ch Wolfgang Korte
|
Re eLetter by Lammers: A D-dimer concentration "corrected" for the hematocrit in serum cannot be determined because the hematocrit cannot be measured in non-anticoagulated samples. This would, however, be required to truely compare the influence of the packed cell volume on the respective D -dimer concentrations. Both loss of D-dimer during the clotting process in serum and matrix effects in citrated plasma (or their combination) seem possible explanations; to our knowledge, neither of these has been further elucidated. It has been suggested in the past that antibodies used in D-dimer assays can be sensitive to more than one molecular species (Pfitzner et al., Thromb Haemost 1997,78:1069), which might further influence the results obtained from different matrices. We are currently evaluating the comparibility of the two matrices in a larger population and hope to be able to answer some of these questions in the future. |
|||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |